Wealthspring Capital’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-130,290
| Closed | -$1.31M | – | 366 |
|
|
2022
Q3 | $1.31M | Buy |
130,290
+218
| +0.2% | +$2.19K | 0.26% | 129 |
|
|
2022
Q2 | $1.29M | Sell |
130,072
-8,301
| -6% | -$82.3K | 0.24% | 135 |
|
|
2022
Q1 | $1.37M | Buy |
138,373
+13,309
| +11% | +$131K | 0.27% | 127 |
|
|
2021
Q4 | $1.25M | Sell |
125,064
-636
| -0.5% | -$6.35K | 0.27% | 138 |
|
|
2021
Q3 | $1.25M | Buy |
125,700
+8,646
| +7% | +$85.7K | 0.3% | 123 |
|
|
2021
Q2 | $1.19M | Hold |
117,054
| – | – | 0.3% | 117 |
|
|
2021
Q1 | $1.18M | Sell |
117,054
-12,826
| -10% | -$129K | 0.32% | 92 |
|
|
2020
Q4 | $1.39M | Buy |
+129,880
| New | +$1.39M | 0.69% | 57 |
|